Immunohistochemistry Evaluation of TGF-β1, SOX-9, Type II Collagen and Aggrecan in Cartilage Lesions Treated with Conditioned Medium of Umbilical Cord Mesencyhmal Stem Cells in Wistar Mice (Rattus novergicus)


  • Bintang Soetjahjo Faculty of Medicine, Brawijaya University, Jalan Veteran Malang 65145, East Java, Indonesia
  • Mohammad Hidayat Faculty of Medicine, Brawijaya University, Jalan Veteran Malang 65145, East Java, Indonesia.
  • Hidayat Sujuti Faculty of Medicine, Brawijaya University, Jalan Veteran Malang 65145, East Java, Indonesia
  • Yuda Fibrianto Faculty of Veterinary Medicine, Gadjah Mada University, Jalan Fauna No. 2 Sleman 55821, Yogyakarta, Indonesia.



Cartilage lesions, conditioned medium, immunohistochemistry, umbilical cord mesenchymal stem cells


Currently, umbilical cord mesenchymal stem cells have the potential to be used as treatment options for any cartilage lesion. This research aimed to evaluate the effects of conditioned medium from umbilical cord mesenchymal stem cells (UC-MSC) on damaged cartilage through the expression of proteins TGF-β1, SOX-9, type II collagen and aggrecan, which are known to be related to chondrogenesis. UC-MSC were isolated from 19-days-pregnant Wistar mice and were cultured using the standard procedure to obtain 80% confluence. Subsequently, the culture was confirmed through a microscopic examination that was driven to be an embryoid body to obtain a pre-condition medium. This research utilized 3-month-old male Wistar mice and was categorized into 6 groups (3 control and 3 treatment groups). Each animal had surgery performed to create a femur condyle cartilage defect. The treatment groups were administered a dose of stem cells at 1 mL/kg. Next, immunohistochemical (IHC) staining was performed to examine the expression of TGF-β1, SOX-9, type II collagen and aggrecan in the 2nd, 3rd, and 4th month of evaluation. The results were analyzed statistically using ANOVA test. For each of the treatment groups, there was increased expression (p < 0.05) in all proteins TGF-β1, SOX-9, type II collagen and aggrecan when compared with control groups at the 2nd, 3rd, and 4th month of evaluation. Pre-conditioned medium from UC-MSC potentially increases the expression of TGF-β1, SOX-9, type II collagen and aggrecan in the damaged cartilage of Wistar mice.


Pawitan JA (2014) Prospect of stem cell conditioned medium in regenerative medicine. BioMed Research International 2014: 1 – 14. doi:10.1155/2014/965849.

Short B, Brouard N, Occhiodoro-Scott T et al. (2003) Mesenchymal stem cells. Archives of Medical Research 34 (6): 565 – 571. doi: 10.1016/j.arcmed.2003.09.007.

Chai C, Leong KW (2007) Biomaterials approach to expand and direct differentiation of stem cells. Molecular Therapy 15 (3): 467 – 480. doi:10.1038/

Kim DW, Staples M, Shinozuka K et al. (2013) Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. International Journal of Molecular Sciences 14 (6): 11692 – 11712. doi:10.3390/ijms140611692.

Song D, Zhong Y, Qian C et al. (2016) Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. BioMed Research International 2016: 1 – 13. doi: 10.1155/2016/2517514.

Yoon HJ, Kim SB, Somaiya D et al. (2015) Type II collagen and glycosaminoglycan expression induction in primary human chondrocyte by TGF-β1. BMC Musculoskelet Disorders 16: 141. doi:10.1186/s12891-015-0599-x.

Li Y, Tian AY, Ophene J et al. (2017) TGF-β stimulates endochondral differentiation after denervation. International Journal of Medical Sciences 14 (4): 382 – 389. doi: 10.7150/ijms.17364.

Yu DA, Han J, Kim BS (2012) Stimulation of chondrogenic differentiation of mesenchymal stem cells. International Journal of Stem Cells 5 (1): 16 – 22. doi: 10.15283/ijsc.2012.


Watanabe H, Tanabe N, Watanabe T, et al. (2008) Metabolic syndrome and risk of development or atrial fibrillation: the Niigata preventive medicine study. Circulation 117 (10): 1255 – 1260. doi: 10.1161/CIRCULATIONAHA.107.744466.

Nagamura-Inoue T, He H (2014) Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World Journal of Stem Cells 6 (2): 195 – 202. doi: 10.4252/wjsc.v6.i2.195.

Mariani E, Pulsatelli L, Facchini A (2014) Signaling pathways in cartilage repair. International Journal of Molecular Sciences 15 (5): 8667 – 8698. doi:10.3390/ijms15058667.

Yoon HJ, Kong SY, Park MH et al. (2013) Aminopropyl carbazole analogues as potent enhancers of neurogenesis. Bioorganic and Medicinal Chemistry 21 (22): 7165 – 7174. doi: 10.1016/j.bmc.2013.08.066.

Taipaleenmaki H (2010) Factors regulating chondrogenic differentiation. Turku, University of Turku Press.

Goldring MB, Marcu KB (2009) Cartilage homeostasis in health and rheumatic diseases. rthritis Research and Therapy 11 (3): 224. doi: 10.1186/ar2592.

Venturin GT, Greggio S, Marinowic DR et al. (2011) Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats. Life Sciences 89 (7 – 8): 229 – 234. doi: 10.1016/j.lfs.2011.06.006.

Cao L, Yang F, Liu G et al. (2011) The promotion of carti-lage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials 32 (16): 3910 – 3920. doi: 10.1016/j.biomaterials.2011.02.014.

Ren X, Yang Z, Xu J et al. (2014) Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Reports 9 (3): 1151 – 1162. doi: 1016/j.celrep.2014.09.044.

Musumeci G, Loreto C, Castorina S et al. (2013) Current concepts in the treat-ment of cartilage damage. A review. Italian Journal of Anatomy Embryology 118 (2): 189 – 203.

Mehrabani D, Babazadeh M, Tanideh N et al. (2015) The healing effect of adipose-derived mesenchymal stem cells in full-thickness femoral articular cartilage defects of rabbit. International Journal of Organ Transplantation Medicine 6 (4): 165 – 175.